Synthesis of a series of NAD+ analogues, potential inhibitors of PARP 1, using ADP conjugates functionalized at the terminal phosphate group


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

A convenient approach has been proposed to the synthesis of nicotinamide adenine dinucleotide (NAD+) mimetics, which comprise morpholino analogues of nucleosides. The approach is based on the use of ADP conjugates containing an amino group, which is tethered to the terminal phosphate through the aliphatic linker by the phosphodiester bond. We have synthesized four series of the NAD+ mimetics, which differ in the type of the modified nucleoside (2-aminomethylmorpholine (Mor) or 2-aminomethyl-4-carboxymethylmorpholine (MorGly) derivatives), in the linker length, and in the manner of the nucleoside attachment to the ADP derivative. We have studied the efficiency of NAD+ mimetics in the inhibition of the auto-poly(ADP-ribosyl)ation by the PARP 1 enzyme. The linker length, the mode of the attachment of the morpholino nucleoside analogue, and the nature of the heterocyclic base of the modified nucleoside were shown to inf luence the inhibition efficiency.

Авторлар туралы

Yu. Sherstyuk

Institute of Chemical Biology and Fundamental Medicine

Email: abramova@niboch.nsc.ru
Ресей, Novosibirsk, 630090

A. Zakharenko

Institute of Chemical Biology and Fundamental Medicine

Email: abramova@niboch.nsc.ru
Ресей, Novosibirsk, 630090

M. Kutuzov

Institute of Chemical Biology and Fundamental Medicine

Email: abramova@niboch.nsc.ru
Ресей, Novosibirsk, 630090

M. Sukhanova

Institute of Chemical Biology and Fundamental Medicine; Novosibirsk State University

Email: abramova@niboch.nsc.ru
Ресей, Novosibirsk, 630090; Novosibirsk, 630090

O. Lavrik

Institute of Chemical Biology and Fundamental Medicine; Novosibirsk State University

Email: abramova@niboch.nsc.ru
Ресей, Novosibirsk, 630090; Novosibirsk, 630090

V. Silnikov

Institute of Chemical Biology and Fundamental Medicine

Email: abramova@niboch.nsc.ru
Ресей, Novosibirsk, 630090

T. Abramova

Institute of Chemical Biology and Fundamental Medicine

Хат алмасуға жауапты Автор.
Email: abramova@niboch.nsc.ru
Ресей, Novosibirsk, 630090

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Pleiades Publishing, Ltd., 2017